Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma.
Liu Z, Zhou J, Yang X, Liu Y, Zou C, Lv W, Chen C, Cheng KK, Chen T, Chang LJ, Wu D, Mao J.
Liu Z, et al. Among authors: chen c, chen t.
Mol Cancer. 2023 Jan 9;22(1):3. doi: 10.1186/s12943-022-01711-9.
Mol Cancer. 2023.
PMID: 36617554
Free PMC article.
Clinical Trial.